Michael R Eledge1, Marcelle Dina Zita1, Karl W Boehme1,2. 1. Department of Microbiology and Immunology, University of Arkansas for Medical Sciences, Little Rock, AR. 2. Center for Microbial Pathogenesis and Host Inflammatory Responses, University of Arkansas for Medical Sciences, Little Rock, AR.
Abstract
PURPOSE OF REVIEW: Mammalian orthoreovirus (reovirus) is a powerful tool for studying viral replication and pathogenesis. Most reovirus infections are subclinical, however recent work has catapulted reovirus into the clinical spotlight. RECENT FINDINGS: Owing to its capacity to kill cancer cells more efficiently than normal cells, reovirus is under development as a therapeutic for a variety of cancers. New efforts have focused on genetically engineering reovirus to increase its oncolytic capacity, and determining how reovirus potentiates immunotherapy. Other recent studies highlight a potential role for reovirus in celiac disease (CeD). Using mouse models of CeD, reovirus caused loss of oral tolerance to dietary antigens, opening the possibility that reovirus could trigger CeD in humans. SUMMARY: We will focus on new developments in reovirus oncolysis and studies suggesting a role for reovirus as a trigger for celiac disease (CeD) that make reovirus a potential friend and foe to human health.
PURPOSE OF REVIEW: Mammalian orthoreovirus (reovirus) is a powerful tool for studying viral replication and pathogenesis. Most reovirus infections are subclinical, however recent work has catapulted reovirus into the clinical spotlight. RECENT FINDINGS: Owing to its capacity to kill cancer cells more efficiently than normal cells, reovirus is under development as a therapeutic for a variety of cancers. New efforts have focused on genetically engineering reovirus to increase its oncolytic capacity, and determining how reovirus potentiates immunotherapy. Other recent studies highlight a potential role for reovirus in celiac disease (CeD). Using mouse models of CeD, reovirus caused loss of oral tolerance to dietary antigens, opening the possibility that reovirus could trigger CeD in humans. SUMMARY: We will focus on new developments in reovirus oncolysis and studies suggesting a role for reovirus as a trigger for celiac disease (CeD) that make reovirus a potential friend and foe to human health.
Authors: A Pansky; P Hildebrand; E Fasler-Kan; L Baselgia; S Ketterer; C Beglinger; M H Heim Journal: Int J Cancer Date: 2000-03-01 Impact factor: 7.396
Authors: B L Liu; M Robinson; Z-Q Han; R H Branston; C English; P Reay; Y McGrath; S K Thomas; M Thornton; P Bullock; C A Love; R S Coffin Journal: Gene Ther Date: 2003-02 Impact factor: 5.250
Authors: Kai-xin Zhang; Yoshiyuki Matsui; Boris A Hadaschik; Cleo Lee; William Jia; John C Bell; Ladan Fazli; Alan I So; Paul S Rennie Journal: Int J Cancer Date: 2010-08-15 Impact factor: 7.396
Authors: Melissa S Maginnis; Bernardo A Mainou; Aaron Derdowski; Elizabeth M Johnson; Roy Zent; Terence S Dermody Journal: J Virol Date: 2008-01-23 Impact factor: 5.103
Authors: Muchen Pan; Ana L Alvarez-Cabrera; Joon S Kang; Lihua Wang; Chunhai Fan; Z Hong Zhou Journal: Nat Commun Date: 2021-07-07 Impact factor: 14.919